XOMA (XOMA) Plans 1-for-20 Reverse Stock Split

XOMA Announces Reverse Stock Split

BERKELEY, Calif., Oct. 14, 2016 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a leader in the discovery and development of therapeutic antibodies, today announced that, at a special meeting of the Company's stockholders held on October 14, 2016, its stockholders voted to approve a reverse stock split of the Companys issued and outstanding common stock.  XOMAs Board of Directors then determined that the split would be at a ratio of 1-for-20.  Upon the effectiveness of the reverse stock split, every 20 shares of XOMA common stock will be converted into 1 share of common stock.  No... More